The U.S. minimally invasive spine fusion market is anticipated to surpass $1.15 billion by 2021, based on an iData Research report, according to Digital Journal.
Here are seven observations:
1. A MIS interbody fusion procedure average selling price is greater than that of a single-level procedure alone.
2. Hospitals and payers will hinder MIS interbody fusion market growth due to high prices.
3. Lateral lumbar interbody fusion procedures possess the highest average selling price and will experience the fastest growth rate in the market. This is because of higher interbody device costs and a higher number of procedure levels.
NuVasive's XLIF approach is the most popular product in the LLIF segment. Medtronic's Direct Lateral Interbody Fusion procedure is also popular.
4. Minimally invasive tranforaminal lumbar interbody fusion procedures account for the greatest portion of total MIS interbody procedures performed. This segment will continue to dominate to 2021.
5. Medtronic dominates the MIPLIF and MITLIF segments, and leads the MIS interbody fusion market.
The company offers various MIS systems: Minimal Exposure Tubular Retractor system; CD Horizon Sextant percutaneous cannulated screw system; CD Horizon Legacy percutaneous PEEK rod system; and CD Horizon Longitude.
6. NuVasive follows Medtronic in market dominance. The company offers various products to complement its XLIF procedure: SLP Plus lateral plating system; Radian facet screw system; and Affix II spinous process plating systems.
7. Other key market players include DePuy Synthes, Globus Medical, Stryker, K2M, Zimmer Biomet, Pioneer Surgical, Alphatec Spine and Aurora Spine.
More articles on devices:
Medtronic, Mazor Robotics, Xtant Medical & more: 18 key notes
Dr. Andrew Cooper 1st in the US to perform meniscus replacement using the NUsurface implant: 5 points
Global orthopedic devices market to increase 4.57% — 4 highlights